WASHINGTON
-- Highly trained and experienced pilots and crews in the Air
National Guard and Air Force Reserve are leaving or have left
military service in part because of the Pentagon's anthrax
vaccine, congressional investigators say in a report released
Tuesday.
Randomly selected guard and reserve troops surveyed in
2000 by the General Accounting Office also reported adverse
reactions to the vaccine at double the rate claimed by the
manufacturer, BioPort Corp., the GAO said.
Military members who have left represent some of the most
experienced and highly trained individuals in the Air National
Guard and Air Force Reserve "and are people not easily
replaced," the GAO said.
"While many factors can and do influence an individual's
decision to participate in the military, a significant number of
pilot and air crew members cited the required mandatory anthrax
immunization as a key reason for reducing their participation or
leaving the military altogether in 2000," the GAO said.
The GAO recommended that Defense Secretary Donald
Rumsfeld require a surveillance program to monitor problems with
the vaccine. The program should ensure complete and appropriate
treatment and follow-up for those who experience problems or who
may have them in the future, the auditors said.
In a response included with the report, the Defense
Department disagreed with the GAO's recommendation and some of
its findings.
Reginald J. Brown, assistant secretary of the Army, cited
a National Academy of Sciences report that concluded there was
no data that pointed to the need for a monitoring program. Brown
also said the GAO's findings on rates of separation by pilots
were not supported by data from the Defense Manpower Data Center
and the GAO did not consider normal turnover rates.
The GAO mailed 1,253 surveys in May 2000 and received 843
responses, with 833 providing useful information. The surveys
were developed with the help of pilots and other aircrew members
of the Air National Guard and Air Force Reserve.
The survey was conducted at the request of Rep. Dan
Burton, R-Ind., chairman of the House Government Reform
Committee.
"Anthrax is a serious threat that our soldiers might face
on the battlefield. At the same time, this vaccine has been
controversial, and it has caused serious reactions in some
individuals," Burton said in a news release.
Anthrax is an acute infectious disease caused by
spore-forming bacteria. Five people were killed in last year's
anthrax attacks by mail. It is considered to be a possible
biological weapon that could be used against U.S. troops.
Hundreds of thousands of U.S. troops have received
vaccines to protect them against anthrax, particularly during
the Persian Gulf War. After a long pause in the inoculation
program, the pace of vaccinations was accelerated last month,
officials said. Some veterans and researchers believe the
vaccine is partly responsible for illnesses reported by Gulf War
veterans.
According to the GAO survey, between September 1998 and
September 2000, about 16 percent of guard and reserve pilots and
air crew had moved to inactive status, left the military or
transferred to another unit -- mostly nonflying positions to
avoid or delay receiving anthrax shots.
About 18 percent of those in or assigned to a unit
indicated they planned to leave soon. The GAO said both groups
ranked the anthrax vaccine as a key factor in their decision.
About 45 percent said they would consider returning if
the anthrax immunization were voluntary.
The GAO estimated that about 37 percent of the service
members surveyed had received one or more anthrax shots as of
September 2000. Of those, 85 percent reported experiencing some
sort of reaction, far higher than the 30 percent claimed by the
vaccine manufacturer.
Each shot generated an average of four or more reported
reactions, some that could have negative effects on the service
member's job, the GAO said.
The GAO said it found two DOD studies of the vaccine, one
in Korea and one in Hawaii, that reported similar reaction
rates.
------
On the Net:
General Accounting Office:
www.gao.gov